DocuSign (DOCU) Initiated with Buy Rating by BTIG
BTIG initiated coverage on DocuSign (NASDAQ:DOCU) with a Buy rating on December 16, 2025, citing confidence in the company's growth potential. On the same date, DocuSign's stock was priced at $67.58. Zacks Investment Research also rates DocuSign highly for growth, assigning an 'A' rating, indicating it as a compelling choice for investors seeking robust growth opportunities.
On December 16, 2025, DocuSign's stock price of $67.58 reflected a decrease of $0.61, or approximately -0.89%. The stock fluctuated between $66.84 and $68.27 during the trading period. Over the past year, DocuSign's stock has traded within a range of $63.41 to $99.71, indicating price volatility.
DocuSign, a prominent entity in the electronic signature and digital transaction management sector, maintains a significant market presence with a capitalization of approximately $13.53 billion. Trading volume for DocuSign on the NASDAQ exchange reached 2,842,012 shares, reflecting active investor interest. For additional insights into DocuSign, investors can explore its history and ownership, mission and vision, financial health, and investor profile.
DocuSign, Inc. (DOCU) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.